RhumbLine Advisers’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-72,806
Closed -$4.94M 2967
2019
Q3
$4.94M Buy
72,806
+35,392
+95% +$2.4M 0.01% 1192
2019
Q2
$2.18M Buy
37,414
+6,812
+22% +$396K ﹤0.01% 1692
2019
Q1
$2.14M Buy
30,602
+895
+3% +$62.7K ﹤0.01% 1664
2018
Q4
$1.91M Buy
29,707
+7,974
+37% +$513K ﹤0.01% 1672
2018
Q3
$1.53M Sell
21,733
-260
-1% -$18.3K ﹤0.01% 1803
2018
Q2
$1.11M Buy
21,993
+1,310
+6% +$66K ﹤0.01% 1963
2018
Q1
$647K Sell
20,683
-340
-2% -$10.6K ﹤0.01% 2117
2017
Q4
$719K Sell
21,023
-3,911
-16% -$134K ﹤0.01% 2092
2017
Q3
$800K Buy
24,934
+270
+1% +$8.66K ﹤0.01% 2089
2017
Q2
$803K Buy
24,664
+1,296
+6% +$42.2K ﹤0.01% 2064
2017
Q1
$736K Buy
23,368
+502
+2% +$15.8K ﹤0.01% 2073
2016
Q4
$672K Buy
22,866
+1,250
+6% +$36.7K ﹤0.01% 2070
2016
Q3
$625K Buy
21,616
+55
+0.3% +$1.59K ﹤0.01% 2073
2016
Q2
$558K Buy
21,561
+805
+4% +$20.8K ﹤0.01% 2128
2016
Q1
$514K Buy
20,756
+70
+0.3% +$1.73K ﹤0.01% 2201
2015
Q4
$728K Buy
20,686
+930
+5% +$32.7K ﹤0.01% 2014
2015
Q3
$418K Buy
19,756
+7
+0% +$148 ﹤0.01% 2355
2015
Q2
$549K Buy
19,749
+25
+0.1% +$695 ﹤0.01% 2264
2015
Q1
$603K Buy
19,724
+2,300
+13% +$70.3K ﹤0.01% 2177
2014
Q4
$557K Sell
17,424
-400
-2% -$12.8K ﹤0.01% 2214
2014
Q3
$505K Sell
17,824
-100
-0.6% -$2.83K ﹤0.01% 2212
2014
Q2
$491K Sell
17,924
-520
-3% -$14.2K ﹤0.01% 2281
2014
Q1
$486K Sell
18,444
-820
-4% -$21.6K ﹤0.01% 2250
2013
Q4
$564K Hold
19,264
﹤0.01% 2183
2013
Q3
$589K Sell
19,264
-99
-0.5% -$3.03K ﹤0.01% 2110
2013
Q2
$614K Buy
+19,363
New +$614K ﹤0.01% 2106